Mr. Rod Senft

Rod Senft
Team: 
Board of Directors
Positions: 

Managing Director, Tricor Pacific Capital, Inc.

Mr. Rod Senft is a founder and Managing Director of Tricor and is based in Vancouver. He is involved in all aspects of acquisitions, operations, and the investment, divestiture and management decisions of the firm.

Mr. Senft is Chairman of Advance Engineered Products and Golden Boy Foods, both current Tricor portfolio companies.

Prior to founding Tricor, Mr. Senft was a Principal at Macluan Capital Corporation. He was previously the Chairman and CEO of Hines Nurseries and SunGro Horticulture (companies owned by three of the Principals prior to the formation of Tricor). Until 1993, Mr. Senft was a Partner of Davis & Company, one of Vancouver's leading law firms. Prior to joining Davis & Company in 1978, Mr. Senft was Secretary and General Counsel for Cargill (Canada) Inc. Before joining Cargill, he practiced law in Winnipeg, Manitoba, with Thompson, Dorfman, Sweatman.

Mr. Senft obtained a Bachelor of Commerce degree and a Bachelor of Law degree from the University of Manitoba.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Pars for Prostate fundraiser: September 22, 2022

The First Annual Pars for Prostate golf fundraiser in support of Prostate Cancer Foundation BC takes place September 22, 2022 at Westwood Plateau Golf Course. For information and to register please visit www.parsforprostate.ca

Dr. Black

Terry Fox Run fundraiser: September 18th, 2022

The 42nd Annual Terry Fox Run is taking place on Sunday September 18, 2022. If you are able, please consider joining and/or donating to our team (tax receipts issued), raising funds for the Terry Fox Foundation's ground-breaking cancer research

Employment

Work at the Vancouver Prostate Centre

Tuesday, September 20, 2022

Dr Mads Daugaard develops an AI cell analytics app which could supercharge biotechnology research

Wednesday, July 20, 2022

With just a tablespoon of blood, B.C. researchers aim to transform cancer treatment